View in EDS HTML Full Text PDF Full Text

Methodological considerations for interpreting ketamine-naltrexone trials in depression.

Saved in:
Bibliographic Details
Title: Methodological considerations for interpreting ketamine-naltrexone trials in depression.
Authors: Bandeira ID; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Jelen LA; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; South London and Maudsley NHS Foundation Trust, London, United Kingdom., Tucciarone JM; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Heifets BD; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States., Rodriguez CI; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Schatzberg AF; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
Source: The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2025 Oct 01; Vol. 28 (10).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41036664
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Methodological considerations for interpreting ketamine-naltrexone trials in depression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bandeira+ID%22">Bandeira ID</searchLink>; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Jelen+LA%22">Jelen LA</searchLink>; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; South London and Maudsley NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tucciarone+JM%22">Tucciarone JM</searchLink>; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Heifets+BD%22">Heifets BD</searchLink>; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Rodriguez+CI%22">Rodriguez CI</searchLink>; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Schatzberg+AF%22">Schatzberg AF</searchLink>; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229815893%22">The international journal of neuropsychopharmacology</searchLink> [Int J Neuropsychopharmacol] 2025 Oct 01; Vol. 28 (10).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9815893 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-5111 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214611457%22">14611457 </searchLink><i>NLM ISO Abbreviation: </i>Int J Neuropsychopharmacol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41036664
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ijnp/pyaf073
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Methodological considerations for interpreting ketamine-naltrexone trials in depression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bandeira ID
      – PersonEntity:
          Name:
            NameFull: Jelen LA
      – PersonEntity:
          Name:
            NameFull: Tucciarone JM
      – PersonEntity:
          Name:
            NameFull: Heifets BD
      – PersonEntity:
          Name:
            NameFull: Rodriguez CI
      – PersonEntity:
          Name:
            NameFull: Schatzberg AF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1469-5111
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: The international journal of neuropsychopharmacology
              Type: main
ResultId 1